Literature data show that intravenous infusion of rHDLs stimulates EPC differentiation and recruitment in rodents [11, 33], exerts beneficial effects on circulating CD34+ cells in patients with recent acute coronary syndrome [51] and increases circulating CD34+/VEGFR2+ cells in patients with type 2 diabetes [35]. This evidence concerns the gene CD34 and type 2 diabetes mellitus.